(Q32016539)
Statements
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities (English)
B R Blazar
A Panoskaltsis-Mortari
F Bracho
M D Krailo
V Shen
S Bergeron
V Davenport
W Liu-Mares
C van de Ven
R Secola
M M Ames
J M Reid
G H Reaman
1 January 2001